What is mass spectrometry?

Mass spectrometry, or MS, measures ions according to their mass-to-charge ratio, written m/z. A sample is first converted into gas-phase ions. An analyser then separates those ions according to m/z, and a detector records their abundance. The resulting mass spectrum plots signal intensity against m/z. Comparing observed signals with a calculated molecular mass can support identification of a peptide sample.

The instrument does not simply place a neutral molecule on a scale. Ionisation adds or removes charged species, and the analyser responds to the resulting ions. Interpretation therefore considers charge, adducts, isotope patterns and instrument accuracy. A reported match should state the expected mass and observed signal rather than merely saying that identity was confirmed.

Electrospray ionisation, ESI, forms charged droplets from a solution under a strong electric field. As solvent evaporates, gas-phase ions emerge and enter the mass analyser. ESI is considered a soft ionisation method because it can transfer peptides with limited fragmentation. It also integrates readily with liquid chromatography, which allows separated components to flow directly into the mass spectrometer in an LC-MS system.

Matrix-assisted laser desorption/ionisation, MALDI, mixes the sample with a light-absorbing matrix on a target plate. A laser pulse transfers energy to the matrix and releases ions from the surface. MALDI often produces predominantly singly charged peptide ions, while ESI commonly produces several charge states. Both approaches can support identity work, but sample preparation, calibration and analyser type affect the data obtained.

A peptide can carry more than one charge, especially during ESI. A molecule with two charges appears at approximately half the m/z of its singly charged form, after accounting for the masses of added protons. Three or more charge states may also appear. This does not mean several different peptides are necessarily present; a series of peaks can be different charged forms of the same molecule.

Software can deconvolute a charge-state envelope to estimate the neutral molecular mass. Analysts check whether the spacing between isotope peaks and neighbouring charge states is internally consistent. Adducts with sodium or other species can shift a signal, and oxidation or incomplete synthesis can produce related masses. A careful report distinguishes the observed ion, its assigned charge and the inferred molecular weight.

Mass spectrometry is strong evidence for molecular mass, but a mass match alone does not describe chromatographic purity. Isomers or sequences with the same nominal composition may share a mass, and a low-level impurity may be less obvious without separation. HPLC, by contrast, separates detected components and estimates relative peak areas but cannot by itself prove which molecular structure produced the main peak.

Using HPLC and MS together addresses these complementary questions. LC-MS links retention information to mass spectra as components leave the column, allowing an analyst to associate an observed mass with a chromatographic peak. More extensive sequence confirmation may require tandem MS or additional methods. For routine document review, researchers should look for a clear expected-versus-observed mass alongside a separate, method-specific purity result and a batch identifier connecting both to the tested sample.

Mass accuracy depends on instrument type, calibration and data processing. A laboratory may use known reference ions to confirm performance before or during a sequence. High-resolution instruments can distinguish very small mass differences, while lower-resolution systems may support a broader molecular-weight check. The report should present precision appropriate to the instrument rather than implying more certainty than the method provides.

Sample preparation and background ions also matter. Salts can suppress ionisation or create adducts, and mixtures can complicate charge-state assignment. Analysts inspect blanks, calibration records and the full spectrum before accepting a match. When the printed result does not include sequence-level evidence, it should be described as observed-mass support for identity—not as proof of every structural detail.